After Recent Leadership Departures, Is the FDA Returning to Form?

(MedPage Today) -- Some experts say the FDA's recent change of heart on a handful of drugs for rare diseases suggests a return to regular order after a tumultuous year, while others argue the flip-flopping signals more chaos.
During the tenure...